Gapping down
In reaction to disappointing earnings/guidance: ECOM -37.1%, BGFV -9.6%, WWW -6.7%, LMNR -4.6%, PHG -1.8%, DAN -1%
Select oil/gas related names showing early weakness: OXY -2%, SDRL -1.4%, RIG -1.4%, RIG -1.3%, BAS -1.3%, NOV -1.2%, SLB -1.1%, HAL -1.1%, EXH -0.8%.
Other news: ANW -10.2% (announced proposed offering of $40 mln of additional 4.00% convertible senior notes due 2018), ATRS -7.7% (received written recommendations from the FDA related to its clinical development program for QuickShot Testosterone), AUY -5.1% (announces C$260.2 mln equity financing; also dg at HSBC), AIV -2.3% (announced it has commenced a public offering of 8.2 mln shares of its common stock), BRX -2.3% (announced offering of 17.5 mln shares of common stock by selling stockholders), SFY -2.2% (announces a revised 2015 capital budget range of $100-125 mln; Eagle Ford wells update), HPP -2.1% (announced it has commenced a public offering of 9.5 mln shares of common stock), BURL -1.2% (announced offering of 12.5 mln shares of common stock by selling stockholders)
Analyst comments: JUNO -4.6% (initiated with a Neutral at Goldman; tgt $52), SNN -2% (downgraded to Neutral from Buy at UBS), MOS -1.5% (downgraded to Sector Underperform from Sector Perform at CIBC), CUZ -1.3% (downgraded to Neutral from Outperform at Robert W. Baird), CE -1.3% (downgraded to Neutral from Buy at Sun Trust Rbsn Humphrey), FE -0.7% (downgraded to Sell from Neutral at Goldman), ED -0.6% (downgraded to Sell at Evercore ISI), COST -0.5% (downgraded to Neutral from Buy at Goldman)
In reaction to disappointing earnings/guidance: ECOM -37.1%, BGFV -9.6%, WWW -6.7%, LMNR -4.6%, PHG -1.8%, DAN -1%
Select oil/gas related names showing early weakness: OXY -2%, SDRL -1.4%, RIG -1.4%, RIG -1.3%, BAS -1.3%, NOV -1.2%, SLB -1.1%, HAL -1.1%, EXH -0.8%.
Other news: ANW -10.2% (announced proposed offering of $40 mln of additional 4.00% convertible senior notes due 2018), ATRS -7.7% (received written recommendations from the FDA related to its clinical development program for QuickShot Testosterone), AUY -5.1% (announces C$260.2 mln equity financing; also dg at HSBC), AIV -2.3% (announced it has commenced a public offering of 8.2 mln shares of its common stock), BRX -2.3% (announced offering of 17.5 mln shares of common stock by selling stockholders), SFY -2.2% (announces a revised 2015 capital budget range of $100-125 mln; Eagle Ford wells update), HPP -2.1% (announced it has commenced a public offering of 9.5 mln shares of common stock), BURL -1.2% (announced offering of 12.5 mln shares of common stock by selling stockholders)
Analyst comments: JUNO -4.6% (initiated with a Neutral at Goldman; tgt $52), SNN -2% (downgraded to Neutral from Buy at UBS), MOS -1.5% (downgraded to Sector Underperform from Sector Perform at CIBC), CUZ -1.3% (downgraded to Neutral from Outperform at Robert W. Baird), CE -1.3% (downgraded to Neutral from Buy at Sun Trust Rbsn Humphrey), FE -0.7% (downgraded to Sell from Neutral at Goldman), ED -0.6% (downgraded to Sell at Evercore ISI), COST -0.5% (downgraded to Neutral from Buy at Goldman)